ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

CRDF Cardiff Oncology Inc

3.50
-0.98 (-21.87%)
May 04 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Cardiff Oncology Inc CRDF NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.98 -21.87% 3.50 00:00:03
Open Price Low Price High Price Close Price Prev Close
3.96 3.12 4.42 3.52 4.48
more quote information »

Recent News

Date Time Source Heading
5/02/202416:05GLOBECardiff Oncology Reports First Quarter 2024 Results and..
4/25/202416:05GLOBECardiff Oncology to Report First Quarter 2024 Results and..
4/08/202416:05GLOBECardiff Oncology Presents Novel Preclinical Data at AACR..
3/07/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202418:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/07/202418:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:05GLOBECardiff Oncology Announces Upcoming Presentations at the..
2/29/202416:07GLOBECardiff Oncology Reports Fourth Quarter and Full Year 2023..
2/29/202416:06GLOBECardiff Oncology Provides Clinical Update on Phase 2..
2/29/202416:05GLOBECardiff Oncology Announces First Patient Dosed in Randomized..
2/29/202416:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/26/202408:00GLOBECardiff Oncology to Present at the Cowen 44th Annual Health..
2/22/202408:00GLOBECardiff Oncology to Report Fourth Quarter and Full Year 2023..
2/06/202416:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/17/202410:30PRNUSCardiff Oncology Announces Publication of Data from Phase 1b..
1/08/202409:12EDGAR2Form 8-K - Current report
11/20/202316:05PRNUSCardiff Oncology to Present at the 35th Annual Piper Sandler..
11/02/202316:06EDGAR2Form 8-K - Current report
11/02/202316:05PRNUSCardiff Oncology Reports Third Quarter 2023 Results and..
11/02/202316:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/26/202316:05PRNUSCardiff Oncology to Report Third Quarter 2023 Financial..
9/26/202316:07EDGAR2Form 8-K - Current report
9/26/202316:05PRNUSCardiff Oncology Announces Positive Clinical Data in..
9/05/202308:00PRNUSCardiff Oncology to Present at Upcoming Investor Conferences..
8/09/202316:06EDGAR2Form 8-K - Current report
8/09/202316:05PRNUSCardiff Oncology Reports Second Quarter 2023 Results and..
8/09/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/07/202316:42EDGAR2Form 8-K - Current report
8/07/202316:05PRNUSCardiff Oncology Announces New Lead Program in First-Line..
7/24/202317:13EDGAR2Form 8-K - Current report
7/24/202317:09PRNUSCardiff Oncology Reports Inducement Grant Under Nasdaq..
6/20/202317:22PRNUSCardiff Oncology Reports Inducement Grant Under Nasdaq..
6/05/202308:00PRNUSCardiff Oncology to Present at the Jefferies Healthcare..

Your Recent History

Delayed Upgrade Clock